Bowel Diseases, Inflammatory
Gastroenterology·MeSH: Inflammatory Bowel Diseases
Prevalence
50.7 / 100K
Incidence
5.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
Frequently asked questions
How many drugs are in development for Bowel Diseases, Inflammatory?
BioSniper tracks 1 drug in development for Bowel Diseases, Inflammatory across 1 company.
How many clinical trials target Bowel Diseases, Inflammatory?
There are 1 clinical trial targeting Bowel Diseases, Inflammatory tracked by BioSniper.
What is the prevalence of Bowel Diseases, Inflammatory?
The estimated prevalence of Bowel Diseases, Inflammatory is approximately 50.7 per 100,000 population.
Deep-dive into Bowel Diseases, Inflammatory
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis